Analytical Overview: Aurora Cannabis Inc (ACB)’s Ratios Tell a Financial Story

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

As of close of business last night, Aurora Cannabis Inc’s stock clocked out at $5.27, up 1.15% from its previous closing price of $5.21. In other words, the price has increased by $1.15 from its previous closing price. On the day, 4.13 million shares were traded. ACB stock price reached its highest trading level at $5.48 during the session, while it also had its lowest trading level at $5.05.

Ratios:

To gain a deeper understanding of ACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.51 and its Current Ratio is at 2.97. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.07.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 296451712 and an Enterprise Value of 295745312. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.16 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at 0.826 whereas that against EBITDA is 24.936.

Stock Price History:

The Beta on a monthly basis for ACB is 1.91, which has changed by -0.23289663 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $7.20, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is 9.56%, while the 200-Day Moving Average is calculated to be 11.14%.

Shares Statistics:

It appears that ACB traded 1.34M shares on average per day over the past three months and 2132950 shares per day over the past ten days. A total of 56.25M shares are outstanding, with a floating share count of 56.02M. Insiders hold about 0.40% of the company’s shares, while institutions hold 14.93% stake in the company. Shares short for ACB as of 1753920000 were 5662902 with a Short Ratio of 4.60, compared to 1751241600 on 6857369.

Revenue Estimates

In the current quarter, 4 analysts expect revenue to total $86.45M. It ranges from a high estimate of $93.7M to a low estimate of $83M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $81.12MFor the next quarter, 4 analysts are estimating revenue of $91.08M. There is a high estimate of $102.8M for the next quarter, whereas the lowest estimate is $84.9M.

A total of 4 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $399.5M, while the lowest revenue estimate was $357.3M, resulting in an average revenue estimate of $371.93M. In the same quarter a year ago, actual revenue was $343.29MBased on 3 analysts’ estimates, the company’s revenue will be $383.17M in the next fiscal year. The high estimate is $385M and the low estimate is $381.5M.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.